Embleema

Healthcare-blockchain developer, Embleema has raised $3.7M in Series A funding round, led by strategic partner Pharmagest, a leading pharmacy software group in Europe, and Techstars. The funds will serve to accelerate the joint development of blockchain-based applications for patients and pharmacies, and further Embleema’s commercial deployment. CEO Robert Chu left his role as Senior Vice President, Global Technology Solutions at IMS Health to start Embleema in June 2017 and is supported by a
Read More